These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28755529)

  • 1. PR3-anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis.
    Mahler M; Damoiseaux J; Ballet V; Dillaerts D; Bentow C; Cohen Tervaert JW; Blockmans D; Boeckxstaens G; Aguilera-Lizarraga J; Csernok E; Vermeire S; Bossuyt X
    Clin Chem Lab Med; 2017 Nov; 56(1):e27-e30. PubMed ID: 28755529
    [No Abstract]   [Full Text] [Related]  

  • 2. PR3-ANCA: a promising biomarker for ulcerative colitis with extensive disease.
    Mahler M; Bogdanos DP; Pavlidis P; Fritzler MJ; Csernok E; Damoiseaux J; Bentow C; Shums Z; Forbes A; Norman GL
    Clin Chim Acta; 2013 Sep; 424():267-73. PubMed ID: 23806819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic role and clinical association of serum proteinase 3 anti-neutrophil cytoplasmic antibodies in Chinese patients with inflammatory bowel disease.
    Xu Y; Xu F; Li W; Li M; Dong S; Zhang Y; Norman GL; Zhao Q; Liu L
    Scand J Gastroenterol; 2020 Jul; 55(7):806-813. PubMed ID: 32568566
    [No Abstract]   [Full Text] [Related]  

  • 4. PR3-ANCA and panel diagnostics in pediatric inflammatory bowel disease to distinguish ulcerative colitis from Crohn's disease.
    Horn MP; Peter AM; Righini Grunder F; Leichtle AB; Spalinger J; Schibli S; Sokollik C
    PLoS One; 2018; 13(12):e0208974. PubMed ID: 30557305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of anti-proteinase 3 antineutrophil cytoplasmic antibodies (anti-PR3 ANCA) as serologic markers in inflammatory bowel disease.
    Arias-Loste MT; Bonilla G; Moraleja I; Mahler M; Mieses MA; Castro B; Rivero M; Crespo J; López-Hoyos M
    Clin Rev Allergy Immunol; 2013 Aug; 45(1):109-16. PubMed ID: 23345025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitis.
    Dobric S; Popovic D; Nikolic M; Andrejevic S; Spuran M; Bonaci-Nikolic B
    Clin Chem Lab Med; 2011 Nov; 50(3):503-9. PubMed ID: 22107137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineutrophil cytoplasmic antibodies: two cases of changing antigenic specificity.
    Saleem R; Oliver M; Rowbottom A; Solomon L
    Ann Clin Biochem; 2012 May; 49(Pt 3):295-9. PubMed ID: 22362085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
    Xin G; Zhao MH; Wang HY
    Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases.
    Bartůnková J; Kolárová I; Sedivá A; Hölzelová E
    Clin Immunol; 2002 Feb; 102(2):162-8. PubMed ID: 11846458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection by flow cytometry of anti-neutrophil cytoplasmic antibodies in a novel approach based on neutrophil extracellular traps.
    Roitsch S; Gößwein S; Neurath MF; Leppkes M
    Autoimmunity; 2018 Sep; 51(6):288-296. PubMed ID: 30994385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Titres of anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease are not related to disease activity.
    Roozendaal C; Pogány K; Hummel EJ; Horst G; Dijkstra G; Nelis GF; Limburg PC; Kleibeuker JH; Kallenberg CG
    QJM; 1999 Nov; 92(11):651-8. PubMed ID: 10542305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis.
    Davis MK; Andres JM; Jolley CD; Novak DA; Haafiz AB; González-Peralta RP
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):409-13. PubMed ID: 18030205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to neutrophil cytoplasma in patients with ulcerative colitis and their first-degree relatives in Thailand.
    Osangthamnont C; Manatsathit S; Pongprasopchai S; Viriyataveekul R; Chaihirunkarn S; Leelakusolvong S; Boonyapisit S
    J Gastroenterol Hepatol; 2001 Aug; 16(8):866-71. PubMed ID: 11555099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
    Radice A; Vecchi M; Bianchi MB; Sinico RA
    Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Frequency and clinical associations of antineutrophil cytoplasmic antibodies. A regional experience].
    Defendenti C; Spina MF; Grosso S; Longo M; Bollani S; Cereda A; Saibeni S; Guercilena G; Atzeni F; Sarzi-Puttini P
    Recenti Prog Med; 2010 Jan; 101(1):16-26. PubMed ID: 20391682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A subset of ulcerative colitis with positive proteinase-3 antineutrophil cytoplasmic antibody.
    Xu J; Yang CH; Chen XY; Li XH; Dai M; Xiao SD
    World J Gastroenterol; 2008 Dec; 14(45):7012-5. PubMed ID: 19058341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role.
    Kull K; Salupere R; Uibo R; Ots M; Salupere V
    Hepatogastroenterology; 1998; 45(24):2132-7. PubMed ID: 9951879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antineutrophil cytoplasmic antibodies and nonspecific ulcerative colitis].
    Rojas G; Siegel F; Jorquera J; Ardiles L; Valderrama G; Mezzano S
    Rev Med Chil; 1996 Apr; 124(4):449-55. PubMed ID: 9110485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [p-ANCA prevalence in ulcerative colitis patients and first-degree relatives].
    Toader E; Durnea C
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):687-93. PubMed ID: 21243793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [p-ANCA and ASCA antibodies in the differential diagnosis between ulcerative rectocolitis and Crohn's disease].
    Lecis P; Germanà B; Papa N; Bertiato G; Doglioni C; Galliani E; Biedo FC
    Recenti Prog Med; 2002 May; 93(5):308-13. PubMed ID: 12050913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.